CA Stock MarketDetailed Quotes

RX Biosyent Inc

Watchlist
  • 11.000
  • -0.100-0.90%
15min DelayMarket Closed Feb 14 16:00 ET
124.04MMarket Cap18.36P/E (TTM)

Biosyent Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
7.72%9.56M
12.33%8.94M
19.30%7.73M
13.12%31.59M
10.88%8.27M
30.63%8.87M
20.01%7.96M
-7.88%6.48M
-2.42%27.93M
3.37%7.46M
Operating revenue
7.72%9.56M
12.33%8.94M
19.30%7.73M
13.12%31.59M
10.88%8.27M
30.63%8.87M
20.01%7.96M
-7.88%6.48M
-2.42%27.93M
3.37%7.46M
Cost of revenue
14.40%2.07M
27.80%1.87M
38.49%1.59M
18.26%5.99M
23.72%1.57M
53.11%1.81M
25.23%1.47M
-20.65%1.15M
-15.27%5.07M
-9.21%1.27M
Gross profit
6.01%7.49M
8.84%7.07M
15.17%6.14M
11.99%25.6M
8.25%6.7M
25.90%7.06M
18.90%6.5M
-4.58%5.33M
0.97%22.86M
6.39%6.19M
Operating expense
12.36%4.83M
9.02%5.12M
4.40%4.05M
13.24%18.06M
8.16%5.19M
13.01%4.29M
20.01%4.69M
12.91%3.88M
10.85%15.95M
40.79%4.8M
Selling and administrative expenses
9.76%4.56M
9.96%4.92M
4.04%3.85M
13.36%17.27M
9.56%4.93M
13.40%4.16M
19.01%4.48M
12.07%3.7M
11.53%15.23M
40.41%4.5M
-Selling and marketing expense
7.91%1.77M
17.36%2.15M
-28.09%1.07M
17.77%7.56M
20.88%2.6M
5.09%1.64M
41.22%1.83M
5.49%1.49M
6.35%6.42M
79.23%2.15M
-General and administrative expense
10.97%2.79M
4.83%2.77M
25.68%2.78M
10.15%9.7M
-0.78%2.34M
19.56%2.51M
7.31%2.64M
16.99%2.21M
15.64%8.81M
17.22%2.35M
Research and development costs
219.93%64.4K
--27.67K
11.57%24.1K
-31.20%83.27K
-14.87%41.54K
29.03%20.13K
--0
26.69%21.6K
-24.68%121.03K
9.64%48.8K
Depreciation amortization depletion
4.38%116.84K
9.11%121.8K
4.14%114.99K
0.96%455.34K
-21.89%121.35K
14.79%111.94K
13.65%111.63K
10.54%110.42K
-1.34%451K
41.38%155.37K
-Depreciation and amortization
4.38%116.84K
9.11%121.8K
4.14%114.99K
0.96%455.34K
-21.89%121.35K
14.79%111.94K
13.65%111.63K
10.54%110.42K
-1.34%451K
41.38%155.37K
Provision for doubtful accounts
--0
--0
--0
180.81%140.32K
-23.86%38.05K
--0
--68.45K
--33.82K
--49.97K
--49.97K
Other operating expenses
1,059.88%83.15K
21.92%45.57K
299.07%64.11K
20.99%117.93K
33.40%57.32K
-68.15%7.17K
205.79%37.38K
-18.76%16.07K
-15.87%97.47K
-10.40%42.97K
Operating profit
-3.84%2.66M
8.36%1.95M
43.96%2.09M
9.08%7.53M
8.56%1.51M
52.95%2.77M
16.09%1.8M
-32.52%1.45M
-16.26%6.91M
-42.24%1.39M
Net non-operating interest income (expenses)
-11.73%242.31K
-17.01%223.78K
64.57%317.23K
136.87%1.06M
36.09%325.79K
114.81%274.52K
358.81%269.65K
749.15%192.76K
766.11%448.65K
1,284.85%239.39K
Non-operating interest income
-11.87%256.89K
-16.79%238.79K
58.14%332.82K
115.13%1.13M
32.61%342.18K
98.30%291.49K
266.65%286.99K
395.29%210.47K
283.66%525.8K
578.53%258.04K
Non-operating interest expense
-14.06%14.58K
-13.46%15.01K
-11.95%15.59K
-11.32%68.41K
-12.11%16.39K
-11.62%16.97K
-11.07%17.34K
-10.53%17.71K
-9.51%77.14K
-10.08%18.65K
Other net income (expenses)
257.05%71.55K
50.97%-26.29K
96.68%-1.53K
-183.97%-63.11K
-15.44%16.56K
-52.28%20.04K
-240.33%-53.63K
-87.13%-46.08K
-4.85%75.16K
-83.33%19.58K
Gain on sale of security
257.05%71.55K
50.97%-26.29K
96.68%-1.53K
-183.97%-63.11K
-15.44%16.56K
-52.28%20.04K
-240.33%-53.63K
-87.13%-46.08K
263.35%75.16K
358.72%19.58K
Income before tax
-2.84%2.98M
6.55%2.15M
50.50%2.41M
14.85%8.53M
12.27%1.85M
54.71%3.06M
22.36%2.02M
-25.64%1.6M
-11.31%7.43M
-35.13%1.65M
Income tax
-6.20%667.21K
6.55%569.77K
50.50%637.7K
5.14%2.07M
-10.74%403.95K
35.16%711.3K
24.00%534.76K
-24.64%423.73K
-5.94%1.97M
-32.33%452.53K
Earnings from equity interest net of tax
Net income
-1.83%2.31M
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
Net income continuous operations
-1.83%2.31M
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
Noncontrolling interests
Net income attributable to the company
-1.83%2.31M
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-1.83%2.31M
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
Diluted earnings per share
0.00%0.199
10.57%0.136
56.70%0.152
21.85%0.541
24.00%0.124
67.23%0.199
25.51%0.123
-23.62%0.097
-10.30%0.444
-32.89%0.1
Basic earnings per share
0.00%0.195
10.74%0.134
56.84%0.149
22.07%0.531
24.74%0.121
68.10%0.195
26.04%0.121
-24.00%0.095
-10.86%0.435
-34.01%0.097
Dividend per share
12.50%0.045
12.50%0.045
12.50%0.045
300.00%0.16
0.00%0.04
0.04
0.04
0.04
0.04
0.04
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 7.72%9.56M12.33%8.94M19.30%7.73M13.12%31.59M10.88%8.27M30.63%8.87M20.01%7.96M-7.88%6.48M-2.42%27.93M3.37%7.46M
Operating revenue 7.72%9.56M12.33%8.94M19.30%7.73M13.12%31.59M10.88%8.27M30.63%8.87M20.01%7.96M-7.88%6.48M-2.42%27.93M3.37%7.46M
Cost of revenue 14.40%2.07M27.80%1.87M38.49%1.59M18.26%5.99M23.72%1.57M53.11%1.81M25.23%1.47M-20.65%1.15M-15.27%5.07M-9.21%1.27M
Gross profit 6.01%7.49M8.84%7.07M15.17%6.14M11.99%25.6M8.25%6.7M25.90%7.06M18.90%6.5M-4.58%5.33M0.97%22.86M6.39%6.19M
Operating expense 12.36%4.83M9.02%5.12M4.40%4.05M13.24%18.06M8.16%5.19M13.01%4.29M20.01%4.69M12.91%3.88M10.85%15.95M40.79%4.8M
Selling and administrative expenses 9.76%4.56M9.96%4.92M4.04%3.85M13.36%17.27M9.56%4.93M13.40%4.16M19.01%4.48M12.07%3.7M11.53%15.23M40.41%4.5M
-Selling and marketing expense 7.91%1.77M17.36%2.15M-28.09%1.07M17.77%7.56M20.88%2.6M5.09%1.64M41.22%1.83M5.49%1.49M6.35%6.42M79.23%2.15M
-General and administrative expense 10.97%2.79M4.83%2.77M25.68%2.78M10.15%9.7M-0.78%2.34M19.56%2.51M7.31%2.64M16.99%2.21M15.64%8.81M17.22%2.35M
Research and development costs 219.93%64.4K--27.67K11.57%24.1K-31.20%83.27K-14.87%41.54K29.03%20.13K--026.69%21.6K-24.68%121.03K9.64%48.8K
Depreciation amortization depletion 4.38%116.84K9.11%121.8K4.14%114.99K0.96%455.34K-21.89%121.35K14.79%111.94K13.65%111.63K10.54%110.42K-1.34%451K41.38%155.37K
-Depreciation and amortization 4.38%116.84K9.11%121.8K4.14%114.99K0.96%455.34K-21.89%121.35K14.79%111.94K13.65%111.63K10.54%110.42K-1.34%451K41.38%155.37K
Provision for doubtful accounts --0--0--0180.81%140.32K-23.86%38.05K--0--68.45K--33.82K--49.97K--49.97K
Other operating expenses 1,059.88%83.15K21.92%45.57K299.07%64.11K20.99%117.93K33.40%57.32K-68.15%7.17K205.79%37.38K-18.76%16.07K-15.87%97.47K-10.40%42.97K
Operating profit -3.84%2.66M8.36%1.95M43.96%2.09M9.08%7.53M8.56%1.51M52.95%2.77M16.09%1.8M-32.52%1.45M-16.26%6.91M-42.24%1.39M
Net non-operating interest income (expenses) -11.73%242.31K-17.01%223.78K64.57%317.23K136.87%1.06M36.09%325.79K114.81%274.52K358.81%269.65K749.15%192.76K766.11%448.65K1,284.85%239.39K
Non-operating interest income -11.87%256.89K-16.79%238.79K58.14%332.82K115.13%1.13M32.61%342.18K98.30%291.49K266.65%286.99K395.29%210.47K283.66%525.8K578.53%258.04K
Non-operating interest expense -14.06%14.58K-13.46%15.01K-11.95%15.59K-11.32%68.41K-12.11%16.39K-11.62%16.97K-11.07%17.34K-10.53%17.71K-9.51%77.14K-10.08%18.65K
Other net income (expenses) 257.05%71.55K50.97%-26.29K96.68%-1.53K-183.97%-63.11K-15.44%16.56K-52.28%20.04K-240.33%-53.63K-87.13%-46.08K-4.85%75.16K-83.33%19.58K
Gain on sale of security 257.05%71.55K50.97%-26.29K96.68%-1.53K-183.97%-63.11K-15.44%16.56K-52.28%20.04K-240.33%-53.63K-87.13%-46.08K263.35%75.16K358.72%19.58K
Income before tax -2.84%2.98M6.55%2.15M50.50%2.41M14.85%8.53M12.27%1.85M54.71%3.06M22.36%2.02M-25.64%1.6M-11.31%7.43M-35.13%1.65M
Income tax -6.20%667.21K6.55%569.77K50.50%637.7K5.14%2.07M-10.74%403.95K35.16%711.3K24.00%534.76K-24.64%423.73K-5.94%1.97M-32.33%452.53K
Earnings from equity interest net of tax
Net income -1.83%2.31M6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M
Net income continuous operations -1.83%2.31M6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M
Noncontrolling interests
Net income attributable to the company -1.83%2.31M6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -1.83%2.31M6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M
Diluted earnings per share 0.00%0.19910.57%0.13656.70%0.15221.85%0.54124.00%0.12467.23%0.19925.51%0.123-23.62%0.097-10.30%0.444-32.89%0.1
Basic earnings per share 0.00%0.19510.74%0.13456.84%0.14922.07%0.53124.74%0.12168.10%0.19526.04%0.121-24.00%0.095-10.86%0.435-34.01%0.097
Dividend per share 12.50%0.04512.50%0.04512.50%0.045300.00%0.160.00%0.040.040.040.040.040.04
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.